Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Discovery Grants Program - Individual

Ryerson University

$19,000.00

The development of targeted therapies using finite element analysis

EF 2007-08

Résumé
The objective of the proposed research program is to develop new treatment techniques for cancer through computational modelling.  Modelling can be used to create and advance innovative treatment methods and to predict the efficacy of current treatments.  This proposal focuses on a new approach to minimally invasive therapy using magnetic nanoparticles and on a treatment monitoring technique using high frequency ultrasound.   The challenge in minimally invasive therapies is the localization of the treatment dose to the tumour while sparing nearby critical tissue, and the treatment of large numbers of disseminated tumour nodules.  Magnetocarcinotherapy (MCT) is a non-invasive approach to combine the detection, imaging, and treatment of cancer into a single modality by using magnetic nanoparticles.  It involves attaching cancer targeting peptides to the particles to enhance their uptake by cancer cells.  Once localized in a tumour region, the particles are rotated to produce localized heating due to the friction between the particles and their surroundings, resulting in the destruction of the tumour while sparing normal tissue. Currently, the only way to assess the outcome of a treatment such as MCT is to expose a patient to the treatment and then image or surgically biopsy the tumour several weeks after the termination of treatment.  The ability to predict the outcome of treatment shortly after delivery will provide the physician the option of altering the treatment to improve its outcome. A common response of cells undergoing cancer treatment is apoptosis (programmed cell death), which is induced within hours of treatment.  It has recently been discovered that cells undergoing apoptosis scatter ultrasound more efficiently.  My research will focus on determining the basis for this effect and to determine of changes that are important for using this technique for treatment monitoring.
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
312235-2006
Name nom
Kumaradas, Carl
Department département
Physics
Organization id
43
Institution établissement
Ryerson University
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2007
Competition year année de concours
2006
Award amount
19000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
13
Committee name en
Mechanical Engineering
Committee name fr
Génie mécanique
Area of application code
1102
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Biomedical engineering
Area of application fr
Génie biomédical
Research subject code
3114
Research subject group en
Physics
Research subject group fr
Physique
Research subject en
Biological and Medical Physics
Research subject fr
Physique biologique et médicale
Partie
2
Nb partie
5
Application title
The development of targeted therapies using finite element analysis
Keyword
NA
Application summary
The objective of the proposed research program is to develop new treatment techniques for cancer through computational modelling.  Modelling can be used to create and advance innovative treatment methods and to predict the efficacy of current treatments.  This proposal focuses on a new approach to minimally invasive therapy using magnetic nanoparticles and on a treatment monitoring technique using high frequency ultrasound.   The challenge in minimally invasive therapies is the localization of the treatment dose to the tumour while sparing nearby critical tissue, and the treatment of large numbers of disseminated tumour nodules.  Magnetocarcinotherapy (MCT) is a non-invasive approach to combine the detection, imaging, and treatment of cancer into a single modality by using magnetic nanoparticles.  It involves attaching cancer targeting peptides to the particles to enhance their uptake by cancer cells.  Once localized in a tumour region, the particles are rotated to produce localized heating due to the friction between the particles and their surroundings, resulting in the destruction of the tumour while sparing normal tissue. Currently, the only way to assess the outcome of a treatment such as MCT is to expose a patient to the treatment and then image or surgically biopsy the tumour several weeks after the termination of treatment.  The ability to predict the outcome of treatment shortly after delivery will provide the physician the option of altering the treatment to improve its outcome. A common response of cells undergoing cancer treatment is apoptosis (programmed cell death), which is induced within hours of treatment.  It has recently been discovered that cells undergoing apoptosis scatter ultrasound more efficiently.  My research will focus on determining the basis for this effect and to determine of changes that are important for using this technique for treatment monitoring.